CIM
HAE icon

Confluence Investment Management’s Haemonetics HAE Stock Holding History

Confluence Investment Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46M Sell
19,455
-1,169
-6% -$75.1K 0.02% 173
2026
Q1 		$1.16M Sell
20,624
-8,063
-28% -$525K 0.02% 203
2025
Q4 		$2.3M Sell
28,687
-8,645
-23% -$581K 0.03% 155
2025
Q3 		$1.82M Sell
37,332
-2,525
-6% -$156K 0.03% 166
2025
Q2 		$2.97M Sell
39,857
-2,865
-7% -$190K 0.04% 146
2025
Q1 		$2.71M Buy
+42,722
New +$2.91M 0.04% 159
2017
Q3 		– Sell
-54,092
Closed -$2.14M – 243
2017
Q2 		$2.14M Sell
54,092
-861
-2% -$35.4K 0.04% 181
2017
Q1 		$2.23M Sell
54,953
-594
-1% -$23.2K 0.05% 176
2016
Q4 		$2.23M Sell
55,547
-643
-1% -$24.2K 0.05% 177
2016
Q3 		$2.04M Buy
56,190
+230
+0.4% +$7.89K 0.05% 176
2016
Q2 		$1.62M Sell
55,960
-1,054
-2% -$31.9K 0.04% 183
2016
Q1 		$1.99M Buy
57,014
+2,877
+5% +$92.9K 0.06% 167
2015
Q4 		$1.75M Buy
54,137
+1,074
+2% +$34.8K 0.06% 176
2015
Q3 		$1.72M Buy
53,063
+4,190
+9% +$158K 0.06% 175
2015
Q2 		$2.02M Buy
48,873
+628
+1% +$26.5K 0.07% 163
2015
Q1 		$2.17M Buy
48,245
+949
+2% +$39.7K 0.08% 159
2014
Q4 		$1.77M Buy
47,296
+59
+0.1% +$2.16K 0.07% 163
2014
Q3 		$1.65M Buy
47,237
+616
+1% +$22K 0.07% 170
2014
Q2 		$1.65M Buy
46,621
+669
+1% +$22.3K 0.08% 170
2014
Q1 		$1.5M Buy
45,952
+14,165
+45% +$541K 0.08% 170
2013
Q4 		$1.34M Buy
31,787
+1,621
+5% +$66.7K 0.07% 174
2013
Q3 		$1.2M Buy
30,166
+553
+2% +$23.2K 0.07% 179
2013
Q2 		$1.22M Buy
+29,613
New +$1.2M 0.08% 168

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Confluence Investment Management's HAE Position: Q2 2026 in Review

Confluence Investment Management reduced its Haemonetics (HAE) stake by 5.7% in Q2 2026, selling an estimated $75.1K and leaving 19,455 shares worth $1.46M. The position accounts for 0.02% of the portfolio, ranked #173.

Confluence Investment Management first reported a position in HAE in Q2 2013 and has held it in 23 quarters since. The position peaked at $2.97M in Q2 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Confluence Investment Management held 19,455 shares of Haemonetics worth $1.46M as of Q2 2026.
  • Confluence Investment Management sold 1,169 Haemonetics shares in Q2 2026, an estimated $75.1K.
  • Haemonetics made up 0.02% of Confluence Investment Management's portfolio in Q2 2026, its #173 holding.
  • Confluence Investment Management first reported a position in Haemonetics in Q2 2013 and has held it in 23 quarters since.
  • Confluence Investment Management's Haemonetics position peaked at $2.97M in Q2 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Confluence Investment Management's 13F filing for Q2 2026, filed 1 Jul 2026.